NCT07573085 Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA) With Self-injury Within Child and Adolescent Mental Health Services
| NCT ID | NCT07573085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Nonsuicidal Self-Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 341 participants |
| Start Date | 2026-05-22 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 341 participants in total. It began in 2026-05-22 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall purpose of the study is to implement and evaluate IERITA (Internet-delivered Emotion Regulation Individual Therapy for Adolescents) within child and adolescent mental health services for adolescents engaging in nonsuicidal self-injury (NSSI) and optimize treatment outcomes for those adolescents at risk of non-remission (continued NSSI).
Eligibility Criteria
Inclusion Criteria: * 13-17 years old * At least one self-injury episode in the past three months * A parent willing to engage in the parent program Exclusion Criteria: * Immediate suicide risk * Global functioning corresponding to a rating ≤40 of the Children's Global Assessment Scale (CGAS) * Social problems needing immediate intervention (e.g., violence within the family) * Ongoing dialectical behavior therapy for adolescents
Contact & Investigator
Johan Bjureberg, PhD
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT07573085 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Nonsuicidal Self-Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07573085 currently recruiting?
Yes, NCT07573085 is actively recruiting participants. Contact the research team at olivia.ojala@ki.se for enrollment information.
Where is the NCT07573085 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07573085 clinical trial?
NCT07573085 is sponsored by Karolinska Institutet. The principal investigator is Johan Bjureberg, PhD at Karolinska Institutet. The trial plans to enroll 341 participants.